{"title":"一项在非洲血统的个体中检验慢性海洛因使用与端粒长度之间关系的试点研究。","authors":"Suky Martinez, Jermaine D. Jones","doi":"10.1016/j.pbb.2023.173631","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Prior research has suggested a possible link between heroin use and shortened telomere<span> length (TL), a marker of cellular aging<span> and genomic stability. We sought to replicate these findings by examining the relationship between TL and heroin use among individuals of African ancestry.</span></span></p></div><div><h3>Methods</h3><p>This cross-sectional study examined TL among 57 participants [17.5 % female; mean age 48.0 (±6.80) years] of African ancestry with Opioid Use Disorder (OUD) and a mean heroin use duration of 18.2 (±10.7) years. Quantitative polymerase chain reaction<span> (qPCR) was used to calculate TL as the ratio between telomere repeat copy number (T) and a single-copy gene, copy number (S). The primary dependent variable was TL (T/S Ratio) measured in kilobase pairs. Covariates included heroin use years and personality traits. Using a hybrid approach, multiple linear regression and Bayesian linear regression examined the association of chronological age, heroin use years and personality traits with TL.</span></p></div><div><h3>Results</h3><p>The multiple linear regression model fit the data well, <em>R</em><sup><em>2</em></sup> = 0.265, <em>F</em>(7,49) = 2.53, <em>p</em> < .026. Chronological age (<em>β</em> = −0.36, <em>p</em><span> = .017), neuroticism (</span><em>β</em> = 0.46, <em>p</em> = .044), and conscientiousness (<em>β</em> = 0.52, <em>p</em> = .040) were significant predictors of TL. Bayesian linear regression provided moderate support for the alternate hypothesis that chronological age and TL are associated, BF<sup>10</sup> = 5.77, <em>R</em><sup><em>2</em></sup> = 0.120. The posterior summary of the coefficient was M = 0.719 (SD = 0.278, 95 % credible interval [−1.28, −0.163]).</p></div><div><h3>Conclusions</h3><p>Contrary to prior studies, these findings suggest that heroin use duration may not be significantly associated with TL among individuals of African ancestry, highlighting the need for more rigorous research to elucidate the complexity of this relationship.</p></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"231 ","pages":"Article 173631"},"PeriodicalIF":3.3000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545475/pdf/","citationCount":"0","resultStr":"{\"title\":\"A pilot study examining the relationship between chronic heroin use and telomere length among individuals of African ancestry\",\"authors\":\"Suky Martinez, Jermaine D. Jones\",\"doi\":\"10.1016/j.pbb.2023.173631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Prior research has suggested a possible link between heroin use and shortened telomere<span> length (TL), a marker of cellular aging<span> and genomic stability. We sought to replicate these findings by examining the relationship between TL and heroin use among individuals of African ancestry.</span></span></p></div><div><h3>Methods</h3><p>This cross-sectional study examined TL among 57 participants [17.5 % female; mean age 48.0 (±6.80) years] of African ancestry with Opioid Use Disorder (OUD) and a mean heroin use duration of 18.2 (±10.7) years. Quantitative polymerase chain reaction<span> (qPCR) was used to calculate TL as the ratio between telomere repeat copy number (T) and a single-copy gene, copy number (S). The primary dependent variable was TL (T/S Ratio) measured in kilobase pairs. Covariates included heroin use years and personality traits. Using a hybrid approach, multiple linear regression and Bayesian linear regression examined the association of chronological age, heroin use years and personality traits with TL.</span></p></div><div><h3>Results</h3><p>The multiple linear regression model fit the data well, <em>R</em><sup><em>2</em></sup> = 0.265, <em>F</em>(7,49) = 2.53, <em>p</em> < .026. Chronological age (<em>β</em> = −0.36, <em>p</em><span> = .017), neuroticism (</span><em>β</em> = 0.46, <em>p</em> = .044), and conscientiousness (<em>β</em> = 0.52, <em>p</em> = .040) were significant predictors of TL. Bayesian linear regression provided moderate support for the alternate hypothesis that chronological age and TL are associated, BF<sup>10</sup> = 5.77, <em>R</em><sup><em>2</em></sup> = 0.120. The posterior summary of the coefficient was M = 0.719 (SD = 0.278, 95 % credible interval [−1.28, −0.163]).</p></div><div><h3>Conclusions</h3><p>Contrary to prior studies, these findings suggest that heroin use duration may not be significantly associated with TL among individuals of African ancestry, highlighting the need for more rigorous research to elucidate the complexity of this relationship.</p></div>\",\"PeriodicalId\":19893,\"journal\":{\"name\":\"Pharmacology Biochemistry and Behavior\",\"volume\":\"231 \",\"pages\":\"Article 173631\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545475/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacology Biochemistry and Behavior\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0091305723001181\",\"RegionNum\":3,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BEHAVIORAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Biochemistry and Behavior","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091305723001181","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
A pilot study examining the relationship between chronic heroin use and telomere length among individuals of African ancestry
Background
Prior research has suggested a possible link between heroin use and shortened telomere length (TL), a marker of cellular aging and genomic stability. We sought to replicate these findings by examining the relationship between TL and heroin use among individuals of African ancestry.
Methods
This cross-sectional study examined TL among 57 participants [17.5 % female; mean age 48.0 (±6.80) years] of African ancestry with Opioid Use Disorder (OUD) and a mean heroin use duration of 18.2 (±10.7) years. Quantitative polymerase chain reaction (qPCR) was used to calculate TL as the ratio between telomere repeat copy number (T) and a single-copy gene, copy number (S). The primary dependent variable was TL (T/S Ratio) measured in kilobase pairs. Covariates included heroin use years and personality traits. Using a hybrid approach, multiple linear regression and Bayesian linear regression examined the association of chronological age, heroin use years and personality traits with TL.
Results
The multiple linear regression model fit the data well, R2 = 0.265, F(7,49) = 2.53, p < .026. Chronological age (β = −0.36, p = .017), neuroticism (β = 0.46, p = .044), and conscientiousness (β = 0.52, p = .040) were significant predictors of TL. Bayesian linear regression provided moderate support for the alternate hypothesis that chronological age and TL are associated, BF10 = 5.77, R2 = 0.120. The posterior summary of the coefficient was M = 0.719 (SD = 0.278, 95 % credible interval [−1.28, −0.163]).
Conclusions
Contrary to prior studies, these findings suggest that heroin use duration may not be significantly associated with TL among individuals of African ancestry, highlighting the need for more rigorous research to elucidate the complexity of this relationship.
期刊介绍:
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.